The changing face of multiple sclerosis clinical trial populations

Author： Uitdehaag Bernard M.J. Barkhof Frederik Coyle Patricia K. Gardner Jason D. Jeffery Douglas R. Mikol Daniel D.

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.8, 2011-08, pp. : 1529-1537

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PRISMS: the story of a pivotal clinical trial series in multiple sclerosis

By Cohen Bruce A. Rivera Victor M.

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 827-838

Informa Healthcare

Access to resources Recommend Favorite

Associated Inosine to interferon: results of a clinical trial in multiple sclerosis

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 131, Iss. 6, 2015-06 ,pp. : 405-410

John Wiley & Sons Inc

Access to resources Recommend Favorite

Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial

By Robinson D. Zhao N. Gathany T. Kim L.-L. Cella D. Revicki D.

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1121-1130

Informa Healthcare

Access to resources Recommend Favorite

Celiac disease in children

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 1, 2015-02 ,pp. : 107-112

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitamin D as a clinical biomarker in multiple sclerosis

By Carlson Noel G

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 3, 2013-05 ,pp. : 231-242

Informa Healthcare

Access to resources Recommend Favorite